Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-03 · accession 0001765581-22-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 | 2022-03-03 | JAZZ | Pearce Samantha | SVP, Head of Europe, Interna | A - Grant | $0.00 | +3,839 | 15.8K | +32% | $0 | |
| 2022-03-09 | 2022-03-05 | JAZZ | Pearce Samantha | SVP, Head of Europe, Interna | F - Tax | $153.96 | -1,836 | 14.0K | -12% | -$282.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-03 | A | A | 3,839 | $0.00 | 15,797 | D | — | — | |
| 2 | Common | Ordinary Shares | 2022-03-05 | F | D | 1,836 | $153.96 | 13,961 | D | — | — |